Loading...
新闻 2021-12-04T22:09:02-08:00

分类

Soleno Therapeutics宣布DCCR(二氮嗪胆碱控释片)治疗Prader-Wii综合征(PWS小胖威利综合征)获美国FDA突破性疗法认定

04月 29日, 2024 |

Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

03月 09日, 2022 |
返回顶部